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Escherichia coli dimethylsulfoxide (DMSO) reductase is a trimeric enzyme with a catalytic dimer (DmsAB) and an integral membrane
anchor (DmsC). Using site-directed mutagenesis, we examined six residues in the periplasmic loop between helices two and three, potentially
involved in menaquinol binding in DmsC. Mutants were characterised for growth, enzyme expression and activity, and 2-n-heptyl-4-
hydroxoquinoline N-oxide (HOQNO) inhibitor binding. Mutations of leucine 66, glycine 67, arginine 71, phenylalanine 73 and serine 75 had
no effect on menaquinol binding. Only a glutamate residue (E87) located in helix three was important for menaquinol binding. E87 was
replaced with lysine, glutamine and aspartate. All three mutants were assembled into the membrane. Neither the lysine nor the glutamine
mutant enzymes were able to support anaerobic growth on glycerol/DMSO minimal media or oxidise lapachol. The glutamine mutant bound
the inhibitor with lower affinity compared to wild-type, whereas in the lysine mutant, binding was almost abolished. The aspartate mutant
behaved as a wild-type enzyme. The data shows that E87 is important for menaquinol binding and oxidation and is likely to act as a proton
acceptor in the menaquinol binding site.
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Escherichia coli can grow on dimethylsulfoxide
(DMSO) as a terminal electron acceptor by utilising
DMSO reductase [1]. DMSO reductase is constitutively
expressed during anaerobic growth on fumarate as a
terminal electron acceptor but repressed by nitrate. The
enzyme is encoded by the dms-operon located on the E.
coli chromosome at approximately 20 min [2]. The
dms-operon has been cloned and sequenced and the0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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fax: +46-46-222-4534.enzyme expressed to high levels [3]. DMSO reductase
can utilise a wide variety of S- and N-oxides such as
DMSO, TMAO, pyridine N-oxide and methionine sulf-
oxide [4].
DMSO reductase is a trimeric enzyme localised to the
cytoplasmic membrane, with two extrinsic subunits and
one membrane anchor. DmsA is the catalytic subunit with
a molecular weight of 85.8 kDa. In the catalytic site,
there is one molybdenum atom coordinated by two
molybdopterin-guanosine dinucleotides (Mo-bisMGD)
[5,6]. DmsB is a 22.7 kDa electron transferring subunit
with four [4Fe–4S] iron–sulfur clusters organised in two
ferredoxin-like motifs as judged by the amino acid
sequence of DmsB. The midpoint potentials of the
iron–sulfur clusters are  50,  120,  240, and  330
mV [7,8]. The  50 mV cluster is close to the mena-
quinol binding site [8,9] and the  120 mV cluster
interacts magnetically with the Mo-bisMGD cofactor in
DmsA [10]. The remaining two clusters may not be
directly involved in electron transfer but may play a
structural role. DmsC is a 30.8 kDa menaquinol oxidising
subunit with eight transmembrane helices and the N- and
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membrane [11,12].
Only one menaquinol binding site has been identified in
DmsC using 2-n-heptyl-4-hydroxoquinoline N-oxide
(HOQNO) inhibitor binding studies [9]. With the proposed
topology of DmsC, the menaquinol binding site is located
close to the periplasmic side of the cell membrane [12].
One residue, DmsC–His65, has been identified as impor-
tant for menaquinol binding [8,9]. When the histidine is
mutated to an arginine, the enzyme loses the ability to
oxidise menaquinol or bind the menaquinol analogue
HOQNO.
We have investigated the effect on growth and quinol
oxidation of mutations in the periplasmic loop between
helices two and three and in glutamate 87 of DmsC (Fig.
1). The E87-residue is located in the periplasmic part of helix
three (Fig. 1A). The residues are conserved in DmsC
sequences in Salmonella typhimurium, Haemophilus influ-
enzae, Yersinia pestis and in the YnfH protein in E. coli (Fig.
1B). We found that the carboxyl-group of glutamate 87 is
important for menaquinol oxidation. The substitution of a
positively charged residue abolishes the ability of mutant
enzyme to support anaerobic growth on glycerol/DMSO
minimal media. The glutamate residue is most likely a proton
acceptor in the menaquinol binding site in DmsC.Fig. 1. Topology and protein alignment of DmsC. (A) A cartoon of the proposed
absolutely conserved residues when six different DmsC sequences from E. coli: Dm
DmsC-2 (Q8Z6Y6); Y. pestis: DmsC (Q9X6B4) and H. influenzae: DmsC (P4500
helices two and three for the six DmsC like sequences in (A). The arrows indica2. Materials and methods
2.1. Strains and plasmids
The E. coli strains used in this study are TG1 ((K12,
D(lac-proAB), supE, thi, hsd D5 FV[traD36 proA+B+lacIq
lacZ DM15]), Amersham Biosciences), HB101 ((supE44,
hsdS20 (rB
 rM
 ) recAB, ara-14, proA2, lacY1, galK2, Smr,
xyl-5 mtl-1), lab collection) and DSS301 ((TG1, Kmr,
DdmsABC), lab collection [11]). TG1 was used for mole-
cular cloning. All cloning procedures were performed with
standard methods as described in Sambrook and Russel
[13].
The plasmids used were pBR322 (AmpR, TetR, Phar-
macia), pTZ18R (AmpR, lacZ, Pharmacia) and pDMS160
(pBR322, (dmsABC)+, [14]). Site-directed mutants were
produced with the QuickChange Site-Directed Mutagene-
sis kit (Stratagene, La Jolla, CA) with pEPK100
(pTZ18R, Sac1/Sal1-fragment of pDMS160 containing
dmsC, this study), as the vector. All mutants were verified
with DNA sequencing (DNA core facility, University of
Alberta). After sequencing, the mutagenised dmsC frag-
ments were subcloned from the high copy number mutant
plasmids into pDMS160 for expression and enzyme
studies.topology and orientation of DmsC from E. coli. Circled residues represent
sC (P18777) and YnfH (P76173); S. typhimurium: DmsC-1 (Q8XEU5) and
2) are compared. (B) Sequence alignment of the periplasmic loop between
te the residues discussed in this work.
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Cells were grown anaerobically at 37 jC on glycerol/
DMSO minimal media or glycerol/fumarate minimal
media [5]. Growth studies were set up in 125 ml flasks
fitted with a side arm and filled to the top. Cell turbidity
was monitored with a Klett-Summerson spectrophotome-
ter equipped with a red filter (no. 66). Cells for prepa-
ration of membranes were grown on glycerol/fumarate
minimal media for 48 h (HB101) or 24 h (DSS301) in
19 l cultures [8]. One percent overnight cultures in
Luria–Bertani medium were used as inocula. Ampicillin
(100 Ag/ml) was regularly used in all cultures. Strepto-
mycin (100 Ag/ml) and kanamycin (40 Ag/ml) were
added to overnight cultures of HB101 and DSS301,
respectively.
2.3. Preparation of membranes
Membranes were prepared by French press lysis as
previously described [5,7]. The buffer used during the
preparation contained 100 mM MOPS/KOH and 5 mM
EDTA, pH = 7. A final concentration of 1 mM dithiothreitol
was added before use. Prior to cell lysis a final concentration
of 2 mM phenylmethanesulfonyl fluoride (PMSF) was
added. Membranes were pelleted twice by centrifugation
in a Beckman 50.2 Ti-rotor at 150,000 g for 60 min.
Before the second spin, PMSF was added to a final
concentration of 2 mM. After a final resuspension in an
appropriate volume, membranes were divided into aliquots
and flash-frozen in N2 (l). Protein concentrations were
determined with a modified Lowry assay containing 1%
(w/v) SDS.
2.4. SDS-PAGE and immunodetection with DmsA and
DmsB antibodies
SDS-PAGE gels (12%) were run in the Laemmli
buffer system [15] and stained with Coomassie brilliant
blue. Samples were solubilised in Laemmli solubilisation
buffer for 5–10 min at room temperature before loading
onto the gels. For immunodetection, protein was trans-
ferred to nitrocellulose membranes and incubated with
polyclonal DmsA and DmsB antibodies [16]. Protein
bands were visualised using goat–anti rabbit antibody
conjugated with horseradish peroxidase (BioRad Labora-
tories) and the ECL detection system (Amersham Phar-
macia Biotech).
2.5. TMAO reduction assays
Benzyl viologen (BV)- and lapachol (LPCH2)-mediat-
ed TMAO reduction was measured with 70 mM TMAO
as the electron acceptor in MOPS buffer at pH = 7. The
BV assay was previously described in Refs. [5,7]. De-
aerated 50 mM MOPS was used as media. BV, Na-
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of 0.2, 0.5 and 70 mM, respectively. After recording a
stable baseline at 570 nm, membranes were added at an
appropriate dilution. The extinction coefficient was 7.4
mmol 1 cm 1 [17]. The LPCH2 assay was previously
described by Rothery et al. [18]. LPCH2 oxidation is
measured semi-anaerobically in stoppered cuvettes with a
buffer containing 100 mM MOPS and 70 mM TMAO at
pH= 7. LPCH2 was added through the teflon stopper to a
final concentration of 0.15 mM to record a baseline prior
to adding membranes at appropriate dilution. LPCH2
oxidation was recorded at 481 nm and the extinction
coefficient is 2.66 mmol 1 cm 1 [18]. A 10 mM stock
solution in ethanol of reduced LPCH2 was used for
activity measurements. Km values for LPCH2 were esti-
mated by measuring the activities at nine different
LPCH2 concentrations. The stock solution of LPCH2 for
Km measurements was 20 mM in ethanol. The resulting
data was fitted with the Briggs–Haldane equation to
estimate the Km value for LPCH2 binding. The specific
activities for the BV and LPCH2 assays are the average
of three measurements given in Amol e min 1 mg
protein 1.
2.6. Preparation of fluorescent molybdopterin derivative
(Form A)
The method is described by Johnson and Rajagopalan
[19]. Membranes prepared from HB101 cells were diluted
with water prior to acidification and mixed with iodine to
produce Form A of the molybdopterin cofactor. Ten
milligrams of protein was used from each sample. Small
aliquots were added to 1 M NH4Cl before recording the
spectra on a Perkin-Elmer LS-50B luminescence spec-
trometer. The excitation spectra and emission spectra
were recorded from 240–420 to 410–520 nm, respec-
tively. The emission wavelength was 442 nm and the
excitation wavelength was 395 nm. The relative amount
of Mo-bisMGD was determined by comparing the fluo-
rescence peak height after subtraction of the fluorescence
background from the chromosomal-encoded Mo-bisMGD-
containing enzymes.
2.7. Fluorescence-quench titration of HOQNO
Binding of HOQNO to DmsC was measured by the
quenching of HOQNO fluorescence and was performed
according to van Ark and Berden [20]. HOQNO was added
from a 0.12 mM stock in ethanol in 2 Al aliquots. Fluores-
cence was recorded at an excitation wavelength of 341 nm
and an emission wavelength of 479 nm. The quenching was
assayed at 0.25, 0.5, 0.75 and 1.0 mg protein ml 1. The
binding site concentration and dissociation constant of
HOQNO were estimated by fitting the data according to
Okun et al. [21]. The Kd is the average of the Kd values
determined at each protein concentration.
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3.1. Mutagenesis of residues in the loop between helix two
and three
Site-directed mutations in five different conserved resi-
dues were introduced in the periplasmic loop between helix
two and three of DmsC (marked with arrows in Fig. 1B).
Two mutated residues, L66D and G67A, are close to H65,
which is known to be important for menaquinol binding and
oxidation [8,9]. Three other mutations were introduced in
the periplasmic loop after H65. The mutations were R71S,
F73D, and S75C. All five residues studied are conserved
between the six DmsC homologues in E. coli, Y. pestis, H.
influenzae, S. typhimurium (DmsC-1 and DmsC-2), and
YnfH of E. coli (Fig. 1B). The mutated dmsC genes were
incorporated into the multicopy plasmid pDMS160 in place
of the wild-type dmsC gene.
All mutant dmsC genes complemented growth on anaer-
obic glycerol/DMSO media in DSS301 (Ddms) and did not
interfere with growth in HB101. In DSS301, the doubling
time for cells harboring plasmids pDMS160DmsC-L66D,
pDMS160DmsC-G67A, pDMS160DmsC-R71S, pDMS160DmsC-
F73D and pDMS160DmsC-S75C mutants were 4.0, 3.8, 4.9,
4.9, and 4.9 h, respectively, compared to 4.1 h for the wild-
type pDMS160. In HB101, the doubling times were 7.3,
5.9, 5.4, 6.0, and 6.8 h, respectively, for cells harboring the
mutant plasmids compared to 6.7 h for the wild-typeFig. 2. BV- and LPCH2-mediated activities in membranes prepared from E.
coli DSS301 harboring pDMS160 plasmids which express DMSO
reductase with DmsC-L66D, G67A, R71S, F73D and S75C mutants.
Assays were carried out as described in Materials and methods. The left
axis and white bars represent the specific BV activity. The right axis and
black bars represent the specific LPCH2 activity.
Fig. 3. Anaerobic growth on glycerol/DMSO minimal media of E. coli
harboring plasmids which express DMSO reductase with DmsC mutants of
the glutamate 87 residue. (A) Growth of E. coli DSS301 harboring plasmids
which express DMSO reductase with DmsC mutants. (B) Growth of E. coli
HB101 harboring plasmids which express DMSO reductase with DmsC
mutants. Symbols: (.) host, (n) wild-type pDMS160, (E) pDMS160DmsC-
E87D, (z) pDMS160DmsC-E87K, (y) pDMS160DmsC-E87Q.pDMS160. Thus, the cell growth doubling times for
DSS301 and HB101 complemented with mutant DMSO
reductase were similar to the doubling time for overex-
pressed wild-type DMSO reductase.
Membranes were prepared from DSS301 cells harboring
plasmids with the five different mutations. We investigated
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BV- and LPCH2-mediated TMAO reduction activity. BV-
mediated TMAO reduction assays the functionality of the
catalytic DmsA-subunit because BV donates electrons to
DMSO reductase at an unknown site, independent of the
menaquinol binding site. The quinol analogue, LPCH2, has
previously been shown to be a useful substrate for DMSO
reductase to assay electron transfer from the quinol binding
site to DmsA [18]. In Fig. 2, the BVand LPCH2 activities are
shown for DSS301 (DdmsABC). DSS301 has no LPCH2
activity as expected since it lacks DMSO reductase. The very
low BV activity observed for the host (DSS301) represents
residual periplasmic TMAO reductase that has co-purified
with the membrane vesicles. The BV and LPCH2 activities
vary about 2-fold and this was consistent with the expression
level of DMSO reductase in the preparations as analysed by
SDS-PAGE and molybdenum cofactor (Form A) content
(data not shown). A comparison of the BV/LPCH2 activity
ratios can be made between the mutants and pDMS160. The
ratio for pDMS160 is 14 and the mutants have ratios of 17,
14, 10, 15 and 23 for the pDMS160DmsC-L66D,
pDMS160DmsC-G67A, pDMS160DmsC-R71S, pDMS160DmsC-
F73D and pDMS160DmsC-S75C, respectively. The variation in
the ratio between the mutant plasmids and pDMS160 is not
significant and it was concluded that the mutations intro-
duced in the loop between helix two and three had no effect
on activity or assembly of DMSO reductase.
3.2. Mutagenesis of glutamate 87 on the periplasmic side of
helix three of DmsC
Glutamate 87 is located close to the periplasmic side of
helix three based on topology determinations [12] and is
conserved in all six homologues of DmsC (Fig. 1B). Site-
directed mutants of E87 to aspartate, lysine or glutamine
were incorporated into DmsC and verified by DNA se-
quencing. The mutants were characterised by the ability of
plasmids expressing the mutant enzymes to complement theFig. 4. SDS-PAGE and Western blot of membranes prepared from E. coli DSS30
The membranes are loaded on the gel at 10 Ag protein per lane. DmsA has a mole
with Coomassie brilliant blue due to its hydrophobicity. DMSOR—purified Dmsanaerobic growth of DSS301 (lacking chromosomally
expressed DMSO reductase) and HB101 on glycerol/DMSO
minimal media (Fig. 3). The plasmids pDMS160DmsC-E87K
and pDMS160DmsC-E87Q were unable to complement growth
in DSS301 whereas the pDMS160DmsC-E87D mutant grew as
well as DSS301/pDMS160 cells (wild-type) (Fig. 3A). In
HB101 cells, the pDMS160DmsC-E87K mutant showed a
dominant negative suppression of growth (Fig. 3B) presum-
ably due to the excess plasmid-encoded mutant enzyme
displacing the wild-type chromosomal enzyme from the
membrane. The enzyme expressed from pDMS160DmsC-
E87Q could support growth in HB101 but at a rate slower
than the wild-type and the pDMS160DmsC-E87D mutant
behaved as enzyme expressed from pDMS160. The dou-
bling times of anaerobic growth on glycerol/DMSO mini-
mal media for the mutants were 4.1 h for both the pDMS160
and pDMS160DmsC-E87D in DSS301. In HB101, the dou-
bling times were 11.8, 7.3, 7.0 and 11.2 h for the host,
pDMS160wt, pDMS160DmsC-E87D and pDMS160DmsC-E87Q,
respectively.
The inability of the lysine and glutamine mutants to
complement anaerobic growth on glycerol/DMSO media in
DSS301 could be due to impaired assembly or loss of
electron transfer from DmsC to DmsB. To investigate
assembly, membranes were prepared from DSS301 cells
harboring the appropriate plasmids and analysed on SDS-
PAGE (Fig. 4, left). The expression levels were also verified
with Western blotting with polyclonal DmsA and DmsB
antibodies (Fig. 4, right). Both the DmsA and DmsC bands
are clearly visible in all three mutants. DMSO reductase was
also expressed well in membranes from the HB101 cells as
judged by the SDS-PAGE (data not shown).
The Mo-bisMGD content associated with the membranes
can be estimated with the Form A assay [19]. The assay
gives a relative estimate on the amount of DmsA associated
with the membrane. The Form A assay of the mutant
enzymes expressed in DSS301 membranes confirms the
results from the SDS-PAGE. In DSS301, the amount of1 harboring plasmids which express DMSO reductase with DmsC mutants.
cular weight of 85.8 kDa and DmsB of 22.7 kDa. DmsC cannot be detected
AB proteins.
Table 2
Characterisation of DMSO reductase in the different glutamate 87 mutants
from the HB101 strains
Mutants BV
(Amol/
(mg prot
min))
LPCH2
(Amol/
(mg prot
min))
BV/LPCH2
ratio
Form A
(a.u.)
Kd
(HOQNO)
(nM)
HB101 14.0 0.87 16 0 10.2
pDMS160 74.7 5.6 13 1.0 7.1
E87D 107.2 6.1 18 1.02 8.1
E87K 62.0 0.46 135 0.68 250–400
E87Q 76.5 0.66 116 1.0 33.0
The specific activities for BV- and LPCH2-mediated TMAO reduction.
Determination of the amount of Mo-bisMGD cofactor associated to the
membrane are given as relative numbers with the HB101 host strain
representing 0 and overexpressed wild-type 1. HOQNO inhibition binding
was studied in HB101 membranes to minimise the presence of background
HOQNO binding.
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pDMS160 (Table 1). In HB101, the Form A assay shows
that there is the same amount of the molybdenum cofactor
per milligram of protein in the enzyme expressed from
pDMS160DmsC-E87D and the pDMS160DmsC-E87Q mutants
as for pDMS160 (Table 2). The enzyme expression from
pDMS160DmsC-E87K is slightly lower; however, in all cases
the mutant plasmids supported reasonable levels of enzyme
expression confirming that the inability to complement
growth was not due to impaired assembly of DMSO
reductase on the membrane.
The specific activities of the BVand LPCH2 activities for
the membranes prepared from DSS301 and HB101 are
presented in Tables 1 and 2, respectively. The specific BV
activities for membranes containing the aspartate, lysine or
glutamine mutant DMSO reductase were close to the values
observed for overexpressed wild-type DMSO reductase.
The specific LPCH2 activities differed significantly com-
paring the E87K and E87Q mutant containing membranes
to the wild-type and the E87D mutant. The E87K and E87Q
mutant enzymes were unable to oxidise LPCH2, whereas the
E87D enzyme retained wild-type oxidation levels in both
DSS301 and HB101. The ratio between BV and LPCH2
oxidation is a good indicator of the functionality of DMSO
reductase. For wild-type enzyme, the ratio is approximately
15 in membranes from both HB101 and DSS301. In the
DSS301 membranes, the ratios are 12, 334 and 91 for the
E87D, E87K and E87Q, respectively (Table 1). The ratios
for DMSO reductase activity in HB101 membranes con-
taining the E87D, E87K and E87Q enzymes are 18, 135 and
116, respectively (Table 2). We determined the Km and Vmax
of DMSO reductase for LPCH2 in membranes isolated from
cells expressing DSSS301/pDMS160 and DSS301/
pDMS160DmsC-E87D. The specific activities of the E87K
and E87Q enzyme-containing membranes were too low for
Km determination. The Km for the pDMS160
DmsC-E87D
membranes was 151 AM compared to 168 AM for wild-
type DMSO reductase. The activity assays confirmed that
menaquinol oxidation is impaired by the insertion of aTable 1
Characterisation of DMSO reductase in the different glutamate 87 mutants
from the DSS301 strains
Mutants BV
(Amol/
(mg prot
min))
LPCH2
(Amol/
(mg prot
min))
BV/LPCH2
ratio
Form A
(a.u.)
Km
(AM)
Vmax
(Amol/
(mg prot
min))
DSS301 3.1 0 – 0 n.d.a n.d.
pDMS160 50.2 3.7 14 1.0 168 11
E87D 81.6 7.0 12 1.47 151 10.1
E87K 66.8 0.20 334 1.27 n.d. n.d.
E87Q 59.1 0.65 91 1.27 n.d. n.d.
The specific activities for BV- and LPCH2-mediated TMAO reduction.
Determination of the amount of Mo-bisMGD cofactor associated to the
membrane are given as relative numbers with the DSS301 host strain
representing 0 and overexpressed wild-type 1.
a n.d.—not determined.lysine or a glutamine in place of E87 in DmsC, whereas
an aspartate substitution has no effect.
HOQNO is a potent inhibitor of menaquinol binding
in DMSO reductase. The Kd for HOQNO binding to
wild-type DMSO reductase has been determined by
stopped-flow measurements to be 6 nM [9]. We measured
the HOQNO binding using a fluorescence quench titra-
tion method for membranes containing all three E87Fig. 5. HOQNO Fluorescence quench titration of membranes prepared from
E. coli HB101 harboring plasmids which express DMSO reductase with
DmsC glutamate 87 mutants. HOQNO binding was measured at 1.0 mg
protein per ml. Symbols: (.) host, (n) wild-type pDMS160, (E)
pDMS160DmsC-E87D, (z) pDMS160DmsC-E87K, (y) pDMS160DmsC-E87Q.
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Membranes isolated from DSS301 cells were unsuitable
for this assay due to very high background binding from
fumarate reductase in this strain [14]. In Fig. 5, the
binding curves for HB101 membranes expressing chro-
mosomal DMSO reductase, the DMSO reductase
expressed by pDMS160 and the three mutants at 1 mg
protein per ml are shown. HOQNO binds with high affinity
to the control membranes with chromosomal DMSO reduc-
tase, membranes expressing pDMS160 DMSO reductase and
membranes expressing pDMS160DmsC-E87D as indicated by
the sharp curvature of the binding curve. The binding curve
of membranes isolated from HB101/pDMS160DmsC-E87Q
has a more gradual curvature indicative of a decreased
binding affinity for HOQNO. The DMSO reductase in
membranes isolated from HB101/pDMS160DmsC-E87K
showed very weak HOQNO binding with a slight curva-
ture. The Kd for HOQNO binding in the membranes
isolated from HB101/pDMS160DmsC-E87D is slightly higher
than that for pDMS160 (8.1 vs. 7.1 nM) but this is within
the experimental error of the technique (Table 2). Mem-
branes isolated from HB101/pDMS160DmsC-E87Q have a Kd
of 33 nM, approximately 4.5 times higher than wild-type
and the HB101/pDMS160DmsC-E87K mutant has a Kd be-
tween 250 and 400 nM. The very low affinity makes an
exact determination of the Kd difficult.4. Discussion
The structure of E. coli DMSO reductase has not been
solved and there is only a proposed topology of DmsC [12].
DmsC provides both the anchor for DmsAB and the
menaquinol binding/oxidation site. In this study, we focused
on amino acids in the loop between helices two and three
that could participate in menaquinol binding and oxidation.
Previous work has shown that mutation of histidine 65 to
arginine abolishes menaquinol binding and the function of
DMSO reductase [8]. This residue is located at the end of
helix two, N-terminal to the region chosen for this study.
This region is highly conserved between six different
sequences of DmsC from E. coli, S. typhimurium (DmsC-
1 and DmsC-2), H. influenzae, Y. pestis and YnfH from E.
coli (Fig. 1).
We mutated leucine 66, glycine 67, arginine 71, phenyl-
alanine 73, serine 75 and glutamate 87. Our study shows
that mutation of most of the selected conserved residues
located in the loop between helices two and three had no
effect on assembly or menaquinol oxidation. Only mutation
of glutamate 87 to lysine or glutamine abolished growth on
glycerol/DMSO minimal media and prevented menaquinol
oxidation in DMSO reductase. This residue is proposed to
be located at the beginning of helix three on the periplasmic
side of the membrane [12].
There are no strong sequence-motifs identified for
menaquinol binding sites although weak sequence motifshave been identified for ubiquinone binding proteins [22].
However, a growing number of high-resolution structures
of menaquinol binding enzymes are becoming available in
the Protein Data Bank. The menaquinol binding site is
composed of the three-dimensional organisation of hydro-
phobic and polar residues drawn from adjacent helices and
loops. One structure that is useful for comparison with the
membrane anchor of DMSO reductase is fumarate reduc-
tase from E. coli. Both enzymes utilise menaquinol and
lack hemes in the menaquinol binding membrane anchor.
Succinate dehydrogenase, formate dehydrogenase and ni-
trate reductase all contain heme at the quinol binding sites
in the membrane anchors [23–25] and we chose not to use
them for our comparison. Fumarate reductase from E. coli
has been studied thoroughly (see Ref. [26] for further
references). Only a small number of amino acid residues
in the structure of FrdABCD define the menaquinol
binding site. In fumarate reductase, the menaquinol bind-
ing pocket is lined by histidine, arginine, glutamate,
phenylalanine and tryptophane from helices one and two
in both FrdC and FrdD. Identifying corresponding amino
acids in DmsC could increase the understanding of how
DmsC folds in the membrane. However, it is difficult to
identify the menaquinol binding residues in DmsC by
examination of conserved residues because the high se-
quence identity between the dmsC genes of different
organisms prevents us from identifying a limited number
of key residues.
Mutation of FrdC–His82 to arginine abolishes menaqui-
nol oxidation and HOQNO binding but does not alter the
assembly, BV activity or the electron paramagnetic reso-
nance signal of the iron–sulfur cluster of fumarate reductase
close to the menaquinol binding site. Mutation of DmsC–
His65 mimics the FrdC–His82 mutation [27–29]. His82 of
fumarate reductase is not involved directly in menaquinol
oxidation but contributes to the hydrogen bonding network
for other residues in the menaquinol binding site of FrdC
(pdb-entry 1FUM, [30]).
Assuming the same function for DmsC–His65, we
hypothesized that DmsC–Leu66 and DmsC–Gly67, lo-
cated downstream from DmsC–His65, and in the peri-
plasmic loop between helices two and three would modify
the binding or access of menaquinol into the binding site
by introducing bulkier or polar residues. These amino
acids were replaced with either aspartate or alanine.
Aspartate is comparable in size to leucine but negatively
charged and alanine has a larger head group than glycine
but maintains the non-polar character. However, no effect
of the DmsC–Leu66Asp or DmsC–Gly67Ala mutations
was observed.
To date no residues in the loops of FrdC and FrdD have
been identified as important for menaquinol binding. How-
ever, the membrane-spanning regions of FrdC and FrdD in
the crystal structure were slightly shifted from the proposed
topology [31,32], and it was important to investigate the loop
regions in the hypothetical DmsC topology. We made site-
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proposed to be in the periplasmic loop between helix two
and three. We studied mutations in DmsC–Arg71, DmsC–
Phe73 and DmsC–Ser75 to serine, aspartate and cysteine,
respectively. We could not observe any physiologic effect of
the mutations and we conclude that the loop between helix
two and three in DmsC is not important for menaquinol
binding.
In this paper, we show that DmsC–Glu87 is important
for menaquinol binding and HOQNO binding. When
DmsC–Glu87 was replaced with glutamine, the ability
to grow on glycerol/DMSO minimal media was lost. The
binding of HOQNO was also affected. The negative
charge of the glutamate is important for correct binding
of menaquinol and the quinol inhibitor but the menaqui-
nol binding site is not sterically restricted, as the smaller
aspartate can substitute for DmsC–Glu87 without any
loss of function. A larger, positively charged amino acid
(lysine) completely abolished menaquinol oxidation and
binding of HOQNO. This is again similar to fumarate
reductase where FrdC–Glu29 in helix one was important
for menaquinol oxidation and HOQNO binding. Gluta-
mate has been shown to be important for menaquinol
binding in several enzymes such as fumarate reductase
both from E. coli and W. succinogenes as well as other
enzymes [26,32,33]. The glutamate probably acts as a
Lewis acid and Bronstead base for a proton from
menaquinol.
Two residues have now been identified as important for
menaquinol binding in DMSO reductase. Mutation of either
DmsC–His65 or DmsC–Glu87 abolished the ability to
grow on glycerol/DMSO minimal media. Although there
are no identified sequence motifs for menaquinol binding,
an emerging theme can be observed. Histidine and gluta-
mate are important for menaquinol oxidation. These resi-
dues are located on the same side of the membrane but not
in the same transmembrane helices. There are also aromatic
residues sandwiched between the aromatic plane and the
isoprenoid chain of menaquinol in published structures of
quinol binding proteins. Likely, there will also be important
aromatic residues in the menaquinol binding pocket of
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